Alkermes (ALKS) Tops Q4 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Alkermes (ALKS) PT Raised to $32 at Goldman Sachs
February 13, 2025 11:44 AM ESTGoldman Sachs analyst Chris Shibutani raised the price target on Alkermes (NASDAQ: ALKS) to $32.00 (from $30.00) while maintaining a Buy rating.
The analyst comments "Relative outperformance for ALKS shares in the context of an inline 4Q, 2025 guidance slightly below consensus expectations and a volatile broader tape, signals in our view, the continued build in investor... More
Jefferies Reiterates Buy Rating on Alkermes (ALKS)
February 12, 2025 1:18 PM ESTJefferies analyst Akash Tewari reiterated a Buy rating and $41.00 price target on Alkermes (NASDAQ: ALKS).
The analyst comments "ALKS reported a beat in Q4 on both total revs ($430M vs $356M cons) & non-GAAP EPS ($1.04 vs $0.72 cons) - Lybalvi revs were $77M... More
